Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Participants

Clinical trial NCT03343626 · COMPLETED

Trial details

NCT number: NCT03343626
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Virus, Zika Zika Virus Disease Flavivirus Infections Healthy Participants

Start date: 2017-11-13
Primary completion: 2018-12-28
Enrollment: 271

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.